In addition, RRAD was identified as a negative regulator of the Warburg effect and cancer progression in breast cancer, nasopharyngeal cancer, hepatocellular carcinoma, and lung cancer19,20,27,29. The gene discussed is RRAD; the disease is nasopharyngeal carcinoma.